Dried Blood Spot Testing for At Home Health
NCT05430139 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-04-26
Summary
DBS (Dried blood spot) is the collection of a small volume of blood on paper cards and subsequent transport to an analytical laboratory. This method is widely used for newborn screening programs around the world to identify inborn errors of metabolism where early diagnosis and treatment can be lifesaving. The World Health Organization and World Anti-Doping Agency (WADA) have independently endorsed DBS as an alternative to conventional testing methods due to its lessened invasiveness, lower collection and transport cost, reduction in sample storage needs, and for some analytes, improved sample stability. There are hundreds of publications describing DBS testing and some commercial ventures offering direct-to-consumer testing using DBS. However, it is not clear if there have been concerted efforts to develop DBS sampling for adults for home collection in concert with high quality, accredited central clinical laboratories. The proposal herein is focused on developing and validating DBS for at home and remote sample collections for routine diagnostic testing.
Conditions
- Diabetes
- Thyroid Diseases
Sponsors & Collaborators
-
Switch Health Solutions Inc.
lead INDUSTRY
Principal Investigators
-
Christopher McCudden, PhD,FCACB,FACB,NRCC-CC,DABC · Eastern Ontario Regional Laboratory Association.
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-31
- Primary Completion
- 2025-01-31
- Completion
- 2025-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD)
NCT07309757 ·Status: NOT_YET_RECRUITING
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers
NCT01009723 ·Status: UNKNOWN
-
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803 ·Status: UNKNOWN
-
A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood
NCT01472523 ·Status: COMPLETED
-
Accuracy of Whole-Blood Testing for Rapid Detection of Pregnancy
NCT00373139 ·Status: COMPLETED
-
Screening for Hemoglobinopathies in Pregnant Women
NCT04029142 ·Status: COMPLETED
-
Evaluation of the Quantra QStat System in Obstetric Patients
NCT05875987 ·Status: COMPLETED
-
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
NCT00533871 ·Status: COMPLETED
-
Evaluation and Validation of New Biomarkers by Mass Spectrometry
NCT01025973 ·Status: COMPLETED
-
Prenatal Aspirin and Postpartum Vascular Function
NCT05653973 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Improving Women's and Children's Health Via Biobanking and Electronic Registry
NCT03938129 ·Status: COMPLETED
-
Utilization of Somatic Tissue Oxygen Saturation Monitoring in Pregnant Women
NCT03196141 ·Status: WITHDRAWN ·Phase: NA
-
NT-proBNP Levels and Obesity in Pregnancy
NCT04049136 ·Status: COMPLETED
-
Embryo Health Study
NCT04528498 ·Status: RECRUITING
-
Assessment of Oxidative Stress Contents in Jordanian Pregnant Women With Preeclampsia
NCT07119034 ·Status: COMPLETED
-
Cardiometabolic Health in First Time Pregnancy
NCT05856318 ·Status: RECRUITING
-
Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico
NCT02381210 ·Status: COMPLETED
-
Doppler and Biological Second Trimester Placental Insufficiency Screening
NCT00465634 ·Status: COMPLETED
-
Baby Detect : Genomic Newborn Screening
NCT05687474 ·Status: COMPLETED
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico
NCT02381197 ·Status: UNKNOWN
-
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
NCT06523569 ·Status: RECRUITING ·Phase: NA
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED
-
NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients
NCT04231591 ·Status: COMPLETED